BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy

Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)

Loading

Please wait while we load your information from QuoteMedia.